ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Pathological and therapeutic roles of bioactive peptide trefoil factor 3 in diverse diseases: recent progress and perspective

Yang, Yiqi; Lin, Ziyang; Lin, Quanyou; Bei, Weijian; Guo, Jiao*广东药学院
Cell Death & Disease2022-1-17DOI: 10.1038/s41419-022-04504-6
21被引6阅读
引用收藏
分享

摘要

Trefoil factor 3 (TFF3) is the last small-molecule peptide found in the trefoil factor family, which is mainly secreted by intestinal goblet cells and exerts mucosal repair effect in the gastrointestinal tract. Emerging evidence indicated that the TFF3 expression profile and biological effects changed significantly in pathological states such as cancer, colitis, gastric ulcer, diabetes mellitus, non-alcoholic fatty liver disease, and nervous system disease. More importantly, mucosal protection would no longer be the only effect of TFF3, it gradually exhibits carcinogenic activity and potential regulatory effect of nervous and endocrine systems, but the inner mechanisms remain unclear. Understanding the molecular function of TFF3 in specific diseases might provide a new insight for the clinical development of novel therapeutic strategies. This review provides an up-to-date overview of the pathological effects of TFF3 in different disease and discusses the binding proteins, signaling pathways, and clinical application.

学科与关键词

关键词
EPIDERMAL-GROWTH-FACTORFACTOR GENE-EXPRESSIONTFF-PEPTIDESEPITHELIAL-CELLSCELLULAR INVASIONBARRIER FUNCTIONMESSENGER-RNASSPASMOLYTIC POLYPEPTIDEEXPERIMENTAL COLITISCANCER CELLS
相关
加载中…
  • Trefoil factor 3: New highlights in chronic kidney disease research
    Lin, Ziyang; Wan, Xiaofen; Zhang, Tao; Huo, Hongyan; Zhang, Xiaoyu; Li, Kunping; Bei, Weijian; Guo, Jiao; Yang, Yiqi*Cellular Signalling, 2022, 100: 110470.被引 1
  • Intestinal Trefoil Factor 3: a new biological factor mediating gut-kidney crosstalk in diabetic kidney disease
    Zhang, Tao; Zhang, Yinghui; Tao, Jie; Rong, Xianglu; Yang, Yiqi*ENDOCRINE, 2023.
  • TFF3、COX-2、HIF-1α在不同胃黏膜病变中的表达意义及与MVD值的相关性研究
    魏计超; 唐英临床合理用药杂志, 2019, (32): 21-24.
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell Death & Disease
发表日期
2022-01-17
卷期
第 13 卷, 第 1 期
页码
62
DOI
10.1038/s41419-022-04504-6
语言
ENGLISH
成果收录
SCIE
资助标注
Key Project of National Natural Science Foundation of China [81830113]; National Key R&D Plan "Research on Modernization of Traditional Chinese Medicine" [2018YFC1704200]; Major Basic and Applied Basic Research Projects of Guangdong Province of China [2019B030302005]; Medical Science and Technology Foundation of Guangdong Province [B2020023]

作者

  • Y

    Yang, Yiqi (第一作者)

    guangdong pharmaceut univ

  • L

    Lin, Ziyang

    guangdong pharmaceut univ

查看全部 5 位作者收起作者
  • L

    Lin, Quanyou

    guangdong pharmaceut univ

  • B

    Bei, Weijian

    guangdong pharmaceut univ

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417